Oracle Just Told Investors What Many Already Knew
Oracle's AI bookings hit numbers that stunned Wall Street, yet the stock sits nearly 49% below its peak while cash flow burns deep into the red. Something has to give, and the next two quarters will settle the argument.
Oracle (NYSE:ORCL | ORCL Price Prediction) trades at $139.56. Shares rose 11.17% in the past week after a run of AI announcements and an Investor Day called as “Accelerating Value Creation”, and that rally lifted view around the stock.
The database and enterprise software giant now earns most of its money from AI cloud infrastructure. Cloud makes up 60% of revenue, up from 48% a year ago. Fears about spending and debt still drove the stock down 48.63% over the past year, from $271.69.
Record AI Bookings Meet a Discounted Multiple
In fiscal Q1, adjusted EPS came in at $1.92, ahead of the $1.74 consensus. Revenue grew 29.6% to $19.34 billion, and cloud infrastructure rose 121%. Remaining performance obligations, meaning signed contracts not yet called, reached $664 billion. GPU usage was 97.9%, and capacity that came up for renewal was re-signed at a 20% premium.
Management raised fiscal 2027 targets to at least $90 billion in revenue and $8.10 in EPS. Even so, the stock trades at a forward P/E of just 16. Over the past 30 days, analysts made 35 upward revisions to fiscal 2027 EPS and only 1 cut. New deals add to the case: Google TPUs from Alphabet (NASDAQ:GOOGL) coming to OCI and a wider enterprise partnership with OpenAI. Building that capacity requires powering, cooling, and networking by somebody, which is why we pulled together seven suppliers behind the AI expansion in a free report here.
Cash Burn and Debt Could Swamp the Growth Story
Free cash flow came in at negative $5.40 billion in Q1, following negative $23.69 billion in fiscal 2026. Full-year capex guidance stands at $90 billion to $95 billion. Interest expense rose 55% to $1.4 billion, and liabilities total $236 billion against $67 billion of equity. The CFO did not offer a date for positive free cash flow: “We have not given the time frame on that.”
Shareholders also took on dilution from a completed $20 billion equity program. Software license revenue fell 15%. Much of the backlog depends on a few large AI customers.
Waiting for Bookings to Become Cash Has Its Logic
The stock still sits below its 200-day moving average of $157.59. Management expects about half of the backlog to convert to revenue within 36 months, but cash flow is still negative. Investors are looking to fiscal Q2, where guidance calls for 30%-34% revenue growth and EPS of $1.85-$1.93, and for proof that the New Mexico and Wisconsin sites stay on schedule.
Wall Street Sees Big Upside as Shares Trail the Market
The average analyst target of $235.80 implies about 69% upside. Targets are only estimates and offer no guarantee. Ratings break down this way:
- Strong Buy: 7
- Buy: 28
- Hold: 7
- Sell: 1
Over one year, Oracle is down 48.63%, while the S&P 500 gained 11.94%. Year to date, the stock is down 27.45% against an index gain of 12.84%. Shares trade at a trailing P/E of 20.
Oracle’s Backlog Is Starting to Turn Into Revenue
Oracle trades at $139.56.
Investor Day confirmed what Q1 already showed: demand for AI capacity is running ahead of supply. The next few earnings reports will show whether the stock can keep climbing, as the $664 billion backlog becomes reported revenue and gross margins level off as management expects.
A forward multiple of 16 already prices in heavy doubt about the balance sheet. Customer-funded hardware and prepayments ease some of the capital burden.
This outlook falls apart if backlog conversion stalls, financing costs climb faster than revenue, or a major AI customer pulls back. Watch quarterly free cash flow and interest expense closely.
Oracle grew revenue 29.6% last quarter while trading at a discount, and whether that gap closes is the key question for investors.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
